Coloma Jason V sold MAZE
June 22, 2026 · Form 4 insider transaction
Coloma Jason V sold 2,040 shares of Maze Therapeutics, Inc. at $26.00 per share, a transaction worth $53.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,040
Price
$26.00
Total value
$53.0K
InsiderColoma Jason V
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 24, 2026
Shares owned after25,930
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.